GIST - GASTROINTESTINAL STROMAL TUMOR
Clinical trials for GIST - GASTROINTESTINAL STROMAL TUMOR explained in plain language.
Never miss a new study
Get alerted when new GIST - GASTROINTESTINAL STROMAL TUMOR trials appear
Sign up with your email to follow new studies for GIST - GASTROINTESTINAL STROMAL TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for advanced GIST: experimental drug NB003 enters Late-Stage trial
Disease control Not yet recruitingThis study tests a new drug called NB003 in people with advanced gastrointestinal stromal tumors (GIST) that have worsened after standard treatments. The trial has two parts: one compares NB003 to another drug (regorafenib) for patients who have failed two prior therapies, and th…
Matched conditions: GIST - GASTROINTESTINAL STROMAL TUMOR
Phase: PHASE2, PHASE3 • Sponsor: Ningbo Newbay Technology Development Co., Ltd • Aim: Disease control
Last updated May 26, 2026 10:34 UTC
-
New global registry aims to unlock secrets of rare gut cancer
Knowledge-focused Not yet recruitingThis study is a registry for people diagnosed with gastrointestinal stromal tumor (GIST), a rare digestive tract cancer. Researchers will collect medical records, scan images, and optional blood or tissue samples from 1000 patients over time. No new treatments or extra visits are…
Matched conditions: GIST - GASTROINTESTINAL STROMAL TUMOR
Sponsor: Universität Duisburg-Essen • Aim: Knowledge-focused
Last updated May 26, 2026 10:47 UTC